75000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Condensed Consolidated Statements of Operations (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Condensed Consolidated Statements of Redeemable Preferred Stock and Stockholders' Deficit (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Nature of Operations and Liquidity
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Accrued Expenses and Other Liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Net Loss Per Share of Common Stock
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Sale of Future Royalties
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Redeemable Preferred Stock and Stockholders' Deficit
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Warrant Liability
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Stock Award Plan and Stock-Based Compensation
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Subsequent Event
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Accrued Expenses and Other Liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Net Loss Per Share of Common Stock (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Warrant Liability (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Stock Award Plan and Stock-Based Compensation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - NATURE OF OPERATIONS AND LIQUIDITY - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Summary of Investments in Held-to-Maturity Securities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Fair Value of Cash Equivalents and Marketable Securities Measured on Recurring Basis and Determined by Valuation Techniques (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Summarizes of Reportable Segment's Financial Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES - Accrued Expenses and Other Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - NET LOSS PER SHARE OF COMMON STOCK - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - NET LOSS PER SHARE OF COMMON STOCK - Computation of Basic and Diluted Loss Per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - NET LOSS PER SHARE OF COMMON STOCK - Securities Excluded from Calculation of Weighted Average Shares Outstanding as their Effect is Antidilutive (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - NET LOSS PER SHARE OF COMMON STOCK - Securities Excluded from Calculation of Weighted Average Shares Outstanding as their Effect is Antidilutive (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Sale of Future Royalties - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT - Private Placement of Series A Preferred Stock and Warrants Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - WARRANT LIABILITY - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - WARRANT LIABILITY - Summary of Valuation Inputs (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - WARRANT LIABILITY - Summary of Warrant Liability Fair Value Estimates and Changes in Level 3 Fair Value Measurements (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - STOCK AWARD PLAN AND STOCK-BASED COMPENSATION - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - STOCK AWARD PLAN AND STOCK-BASED COMPENSATION - Stock Option Activity for Employees and Non-Employees (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - STOCK AWARD PLAN AND STOCK-BASED COMPENSATION - Summary of Assumptions Used in Black Scholes Model to Estimate Fair Value of Stock Options (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - STOCK AWARD PLAN AND STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense Included in the Company's Consolidated Statements of Operations (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - RELATED PARTY TRANSACTIONS - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Subsequent Event - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Deferred Offering Costs Included In Accrued Expenses And Other Current Liabilities
Deferred offering costs included in accrued expenses and other current liabilities.
Related Party Tax Expense, Due to Affiliates, Current
Settlement payment
Performance-Based Restricted Stock Units
Performance-based Restricted Stock Units
Performance-based restricted stock units.
Performance-based restricted stock units ("PRSUs")
Lease commencement date
Lease Commencement Date
Lease commencement date.
Significant Risks and Uncertainties
Significant Risks And Uncertainties Policy [Text Block]
Disclosure of accounting policy for significant risks and uncertainties.
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Preferred Stock, Shares Issued, Total
Preferred stock, shares issued
Preferred Stock, Shares Issued
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Fair value, ending balance
Fair value, beginning balance
Increase (Decrease) in Accounts Payable
Increase (Decrease) in Accounts Payable, Total
Accounts payable
Plan Name
Plan Name [Axis]
Entity Current Reporting Status
Entity Current Reporting Status
Sale Of Future Royalties [Abstract]
Sale of future royalties.
Proceeds from exercise of Tranche A warrants
Proceeds from Warrant Exercises
Expenses
Operating Expenses [Abstract]
Fair Value, Inputs, Level 2 [Member]
Level 2
Weighted-Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Number of shares of common stock authorized
Common stock, shares authorized
Common Stock, Shares Authorized
Tranche Three
Share-Based Payment Arrangement, Tranche Three [Member]
Consulting Fees
Consulting Fees [Member]
Consulting fees.
Temporary Equity, Par or Stated Value Per Share
Temporary equity par value
Par value
Product and Service
Product and Service [Axis]
Document Fiscal Period Focus
Document Fiscal Period Focus
Capitalized Computer Software, Amortization
Amortization of capitalized software
Geoffrey Race [Member]
Geoffrey race.
Mr. Geoffrey Race
Entity Shell Company
Entity Shell Company
Gross proceeds before deducting placement agent fees and other expenses
Gross Proceeds Before Deducting Placement Agent Fees And Other Expenses
Gross proceeds, before deducting placement agent fees and other expenses.
Temporary Equity, Shares Outstanding
Shares outstanding
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
Issuance of common stock upon exercise of warrants
Segment Reporting, Policy [Policy Text Block]
Segment Information
Cash and Cash Equivalents, at Carrying Value, Ending Balance
Cash and Cash Equivalents, at Carrying Value, Beginning Balance
Cash and Cash Equivalents, at Carrying Value, Total
Cash and cash equivalents
Cash and Cash Equivalent
Common Stock, Shares, Issued, Total
Common stock, shares issued
Common Stock, Shares, Issued
Remeasurement of Liability for Sale of Future Royalties
Remeasurement of liability for sale of future royalties.
Remeasurement of liability related to sale of future royalties
Statement [Table]
Statement [Table]
Refundable regulatory fee
Refundable regulatory fee current.
Refundable regulatory fee current
Potential future milestone payments.
Potential Future Milestone Payments
Additional milestone payments
Monthly rental rate
Monthly Rental Rate
Monthly rental rate.
Fair value of common stock on grant date (in dollars per share)
Weighted average grant date fair value per share of common stock
Weighted-average fair value of options granted during the period
Exercise of tranche A warrants (in shares)
Stock Issued During Period, Shares, Exercise of Warrants
Stock issued during period shares exercise of warrants.
Statement [Line Items]
Statement [Line Items]
Expired (in dollar per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Common Stock Warrants
Warrant [Member]
Warrant
Other Expense [Member]
Entity Filer Category
Entity Filer Category
Expired (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expired in Period
Share-based compensation arrangement by share-based payment award, options, expired in period.
Liabilities and Equity
Total liabilities, redeemable preferred stock and stockholders' deficit
Total liabilities, redeemable preferred stock and stockholders' deficit
Payables and Accruals [Abstract]
Purchase of marketable securities
Payments to Acquire Marketable Securities
Purchase of marketable securities
Exercisable at the end of the period (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Annual interest rate on interest expense
Annual Interest Rate On Interest Expense
Annual interest rate on interest expense.
Marketable securities weighted average remaining maturity period
Marketable securities weighted average remaining maturity period.
Number Of Hours Per Month Services Provided
Number of hours per month services provided.
Number of hours per month services provided
Estimated Fair Value of Warrants
Estimated fair value of warrants.
Estimated fair value of warrants
Tranche B Warrants [Member]
Tranche B warrants.
Tranche B Warrants
Shares Issued, Price Per Share
Purchase price per share
Subsequent Event [Line Items]
Research and development and general and administrative expenses
Research and development and general and administrative expenses.
Total
Goodwill, Ending Balance
Goodwill, Beginning Balance
Goodwill, Total
Goodwill
Goodwill
Common Stock Options
Investment income
Investment Income, Interest
Restricted Cash
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
Research and development costs and other accrued expenses
Accrued Research And Development Costs And Other Expenses Current
Represents the carrying value, as of the balance sheet date, of obligations incurred through that date and payable for research and development costs. It is used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle, if longer).
Additional Paid in Capital, Common Stock, Ending Balance
Additional Paid in Capital, Common Stock, Beginning Balance
Additional paid-in capital
Additional Paid in Capital, Common Stock
Notice Period To Change Beneficial Ownership Limitation
Notice period to change beneficial ownership limitation.
Notice period to change beneficial ownership limitation
Deferred offering cost
Deferred offering cost.
Deferred offering costs
Common Stock, Convertible, Conversion Price, Increase
Conversion price
SIGNIFICANT ACCOUNTING POLICIES
Significant Accounting Policies
Significant Accounting Policies [Text Block]
Risk-Free Interest Rate
Measurement Input, Risk Free Interest Rate [Member]
Vesting [Domain]
Drug Product Material Expenses And Associated Costs [Member]
Drug product material expenses and associated costs.
Drug Product Material Expenses and Associated Costs
Shares issued
Granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Computation of Basic and Diluted Loss Per Share
Proceeds from exchange of preferred stock
Proceeds from Issuance of Preferred Stock and Preference Stock
Earnings Per Share, Basic, Total
Earnings Per Share, Basic
Net loss per share of common stock - basic
Net loss per share, basic
Probability of Milestone Event Achievement
Probability of Milestone Event Achievement [Member]
Probability of Milestone Event achievement.
Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain
Unrealized Gains
PRSU'S outstanding
Outstanding at the beginning of period (in shares)
Outstanding at the end of the period (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Stock Issued
Total current liabilities
Liabilities, Current
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities:
Exercise price per unit
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price
Summary of Warrant Liability Fair Value Estimates and Changes in Level 3 Fair Value Measurements
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Warrant Liability
Warrant Liability [Member]
Warrant liability.
Consolidation Items [Domain]
Equity, Attributable to Parent [Abstract]
Stockholders' deficit
Entity Small Business
Entity Small Business
Increase (Decrease) in Accrued Liabilities, Total
Accrued expenses and other current liabilities
Increase (Decrease) in Accrued Liabilities
Consultant Option [Member]
Consultant option.
Consultant Option
Retained Earnings (Accumulated Deficit), Ending Balance
Retained Earnings (Accumulated Deficit), Beginning Balance
Retained Earnings (Accumulated Deficit), Total
Accumulated deficit
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Nature of Operations and Liquidity
Nature of Operations [Text Block]
Preferred Stock [Member]
Preferred Stock
PRSU'S cancelled
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Cancelled/Forfeited (in shares)
Total intrinsic value of the stock options exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value
Warrants and Rights Outstanding, Measurement Input
Warrants and Rights Outstanding, Measurement Input
Stock Award Plan and Stock-Based Compensation
Share-Based Payment Arrangement [Text Block]
Lease Contractual Term [Axis]
Weighted Average Number of Shares Outstanding, Diluted, Adjustment
Weighted Average Number of Shares Outstanding, Diluted, Adjustment, Total
Dilutive effect
Liability related to the sale of future royalties
Liability Related To Sale Of Future Royalties
Liability related to the sale of future royalties.
Amendment Flag
Amendment Flag
Product and Service
Product and Service [Domain]
Loss Contingencies [Line Items]
Loss Contingencies [Line Items]
Schedule of Held-to-Maturity Securities [Line Items]
Shares of common stock to purchase by warrant
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Initial upfront payment received
Initial Upfront Payment Received
Initial upfront payment received.
Liabilities and Equity [Abstract]
Liabilities, Redeemable Preferred Stock and Stockholders' Deficit
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Net cash used in operating activities
Net cash used in operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Common Stock
Common Stock [Member]
Granted (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Entity Address, Address Line One
Entity Address, Address Line One
Non-cash interest expense for the sale of future royalties
Non Cash Interest Expense For The Sale Of Future Royalties
Non-cash interest expense for the sale of future royalties
Summary of Assumptions Used in Black Scholes Model to Estimate Fair Value of Stock Options
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Fair Value Hierarchy and NAV [Axis]
Earnings Per Share [Abstract]
Warrants Exercised
Warrants exercised
Warrants exercised
Investment Type [Axis]
Class of Warrant or Right [Axis]
Document Type
Document Type
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Entity Central Index Key
Entity Central Index Key
Investments, Debt and Equity Securities [Abstract]
Valuation Approach and Technique [Axis]
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Net decrease in cash, cash equivalents and restricted cash
Subsequent Event Type [Domain]
Changes in fair value of the warrant liability
Fair Value Adjustment of Warrants
Changes in fair value of the warrant liability
Securities outstanding excluded from the calculation of weighted average shares outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Common stock, par value (in dollars per share)
Common Stock, Par or Stated Value Per Share
Share-Based Payment Arrangement, Tranche One [Member]
Tranche One
Weighted-Average Remaining Contractual Term Outstanding (Years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Sale Of Future Royalties [Table]
Sale Of Future Royalties [Table]
Sale of future royalties.
Adjustments to Additional Paid in Capital, Stock Split
Adjustments due to the rounding impact from the reverse stock split for fractional shares
Exercised (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Valuation Technique, Black-Scholes-Merton Model [Member]
Black-Scholes Option Pricing Model
Marketable securities
Marketable Securities
Marketable Securities, Total
Stock Issued During Period, Value, Restricted Stock Award, Gross
Vesting of performance-based restricted stock units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Time Period Between Valuation Date and Milestone Event [Member]
Time period between valuation date and Milestone Event.
Time Period Between Valuation Date and Milestone Event
Current Fiscal Year End Date
Current Fiscal Year End Date
Document Quarterly Report
Document Quarterly Report
Entity Address, State or Province
Entity Address, State or Province
Non-cash incremental stock-based compensation cost
Share Based Goods And Services Non Cash Incremental Stock Based Compensation Cost
Share based goods and services non cash incremental stock based compensation cost.
Preferred Stock, Shares Outstanding, Ending Balance
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred stock, shares outstanding
Preferred Stock, Shares Outstanding
Class of Warrant or Right [Domain]
Conversion of Stock, Shares Converted
Conversion of stock converted
Marketable Securities, Current
Marketable securities
Accrued bonus
Accrued Bonuses, Current
Subsequent Event
Subsequent Event [Member]
Adjustments To Additional Paid In Capital Costs Earnings Related To Stock Issuance
Adjustments to additional paid in capital costs earnings related to stock issuance.
Costs related to issuance of common stock and warrants
Marketable Securities
Marketable Securities, Policy [Policy Text Block]
Increase in number of shares authorized for issuance
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized
Fair Value Measurement Inputs and Valuation Techniques [Table]
Measurement Input, Expected Term [Member]
Term to Expiration
Antidilutive Securities
Antidilutive Securities [Axis]
Exercise price of pre-funded warrants.
Exercise Price of Pre-funded Warrants
Exercise price of pre-funded warrants
Vesting percentage
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage
Dr. Kaul
Dr Kaul [Member]
Dr Kaul.
Legal Fees
Legal Fees [Member]
Legal fees.
Schedule of Stock-Based Compensation Expense Included in the Company's Consolidated Statements of Operations
Share-Based Payment Arrangement, Cost by Plan [Table Text Block]
Related Party Transaction [Axis]
Debt Securities, Held-to-Maturity [Table]
Preferred Stock, Value, Issued, Ending Balance
Preferred Stock, Value, Issued, Beginning Balance
Preferred Stock, Value, Issued, Total
Preferred Stock, Value, Issued
Preferred stock; $0.0001 par value; 100,000,000 shares authorized; none issued or outstanding as of September, 2025 and December 31, 2024
Minimum [Member]
Minimum [Member]
Minimum
Financial Instrument [Axis]
Current assets
Assets, Current [Abstract]
Deferred issuance costs included in accounts payable
Deferred Issuance Costs Included In Accounts Payable
Deferred issuance costs included in accounts payable.
Settlement Agreement
Settlement Agreement [Member]
Settlement agreement.
Cash, cash equivalents and restricted cash
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation [Abstract]
Accrued expenses and other current liabilities
Accounts Payable and Other Accrued Liabilities, Current
Accrued expenses and other current liabilities
U S Food And Drug Administration [Member]
FDA [Member]
U S Food And Drug Administration Member
Fair Value, Inputs, Level 3 [Member]
Level 3
Liabilities:
Liabilities, Fair Value Disclosure [Abstract]
Initial term of agreement
Initial Term Of Agreement
Initial term of agreement.
Segment Reporting [Abstract]
Fair Value of Cash Equivalents and Marketable Securities Measured on Recurring Basis and Determined by Valuation Techniques
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Current liabilities
Liabilities, Current [Abstract]
Nature Of Operations And Liquidity [Line Items]
Nature Of Operations And Liquidity [Line Items]
Nature of operations and liquidity.
Related Party Transactions [Abstract]
Other Income
Other income
Commitments and Contingencies
Commitments and contingencies (Note 9)
General and Administrative
General and Administrative Expense [Member]
Capitalized Computer Software, Net, Ending Balance
Capitalized Computer Software, Net, Beginning Balance
Capitalized Computer Software, Net, Total
Capitalized software, net
Capitalized Computer Software, Net
Restricted cash balances as collateral for corporate credit cards
Restricted cash
Restricted Cash, Current
2013 Equity Incentive Plan
Twenty Thirteen Equity Incentive Plan [Member]
Twenty thirteen equity incentive plan.
Fair Value Measurement Inputs and Valuation Techniques [Abstract]
Series A Convertible Preferred Stock [Member]
Series A convertible preferred stock.
Series A Convertible Preferred Stock
Sale Of Future Royalties [Line Items]
Sale Of Future Royalties [Line Items]
Sale of future royalties.
Consulting Agreement
Consulting Agreement [Member]
Consulting agreement.
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Net loss
Net loss
Lease Contractual Term [Domain]
Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss
Amortized Cost
Amortized Cost
Nature Of Operations And Liquidity [Table]
Nature Of Operations And Liquidity [Table]
Disclosure pertaining to nature of operations and liquidity.
Loss Contingencies [Table]
Weighted average shares of common stock outstanding - basic
Weighted Average Number of Shares Outstanding, Basic, Total
Weighted average shares outstanding, basic
Weighted average shares of common stock outstanding
Employees [Member]
Employees.
Employees
Scenario [Axis]
Temporary Equity [Abstract]
Redeemable preferred stock
Total Intrinsic Value Exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Offering cost
Offering Cost, Expense
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Lease description
Lease Description
Lease description.
Outstanding shares of common stock reverse stock splits
Adjustments due to the rounding impact from the reverse stock split for fractional shares (in shares)
Stock Issued During Period, Shares, Reverse Stock Splits
Net proceeds from issuance of private placement
Proceeds from Issuance of Private Placement
Subsequent Event
Gross Proceeds From Issuance Of Private Placement
Gross proceeds from issuance of private placement.
Gross proceeds from issuance of private placement
Related Party Transactions Disclosure [Text Block]
Related Party Transactions
APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total
Stock-based compensation
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Marketable securities maturity period
Marketable securities maturity period.
Balance
Balance
Equity, Attributable to Parent
Total stockholders' deficit
Preferred stock, par value (in dollars per share)
Preferred Stock, Par or Stated Value Per Share
Basis of Presentation
Basis of Accounting, Policy [Policy Text Block]
Regus
Regus [Member]
Regus.
Statement of Stockholders' Equity [Abstract]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Unrealized Losses
Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss
Unrealized Losses
Temporary Equity, Par Value
Series A convertible preferred stock; $0.0001 par value; 200,000 shares authorized; 3,296 issued and outstanding; liquidation preference of $0 as of March 31, 2026 and December 31, 2025
Tranche Two
Share-Based Payment Arrangement, Tranche Two [Member]
Valuation Approach and Technique [Domain]
Series A Preferred Stock
Series A Preferred Stock [Member]
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Foreign Currency Transaction Gain (Loss), before Tax, Total
Gain (Loss), Foreign Currency Transaction, before Tax
Foreign exchange losses
Foreign exchange (losses) gains
Entity Address, Address Line Two
Entity Address, Address Line Two
Percentage Of Share Total Agreed To Grant
Percentage of share total agreed to grant.
Percentage of share total agreed to grant
Warrants and Rights Note Disclosure [Abstract]
Shares Issuable Pursuant to Stock Options
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Schedule of Accrued Expenses and Other Liabilities
Schedule of Accrued Liabilities [Table Text Block]
Supplemental disclosure of non-cash financing activities
Noncash Investing and Financing Items [Abstract]
Measurement Input, Discount Rate [Member]
Discount Rate
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Segment Reporting, Other Segment Item, Amount
Other segment expense, net
Plan Name
Plan Name [Domain]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Upfront payment for royalty interest sold
Upfront Payment
Upfront payment.
Up front payment
Warrant Liability
Warrant liability.
Warrant liability
Refundable regulatory fee
Refundable regulatory fee policy.
Refundable regulatory fee Policy Text Block
Refundable Regulatory Fee
Class of Warrant or Right, Outstanding
Warrants exercised
Payment of deferred offering costs
Payment of Deferred Offering Costs
Payment of deferred offering costs.
Payment of deferred offering costs
Settlement Liabilities, Current
Accrued settlement payment
Related and Nonrelated Parties [Axis]
Class Of Warrant Or Right [Table]
Class of Warrant or Right [Table]
Lease rentable square feet
Area of Real Estate Property
Entity Address, City or Town
Entity Address, City or Town
Loss on issuance of convertible preferred stock and warrants
Loss on Issuance of Convertible Preferred Stock and Warrants
Loss on issuance of convertible preferred stock and warrants.
Proceeds Received from Issuance of Warrants and Series A Preferred Stock
Proceeds received from issuance of warrants and series A preferred stock.
Gross proceeds received from issuance of warrants and series A preferred stock
Number of Reportable Segments
Number of reportable segments
Security Exchange Name
Security Exchange Name
Significant accounting policies.
Significant Accounting Policies [Line Items]
Significant Accounting Policies [Line Items]
Counterparty Name
Counterparty Name [Axis]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
PRSU'S vested
Outstanding Common Stock Percentage
Outstanding common stock percentage.
Outstanding common stock percentage
Tranche A Warrants [Member]
Tranche A warrants.
Tranche A Warrants
Measurement Input Type [Domain]
Antidilutive Securities, Name
Antidilutive Securities, Name [Domain]
Stockholders' Equity Note [Abstract]
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Ending Balance
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning Balance
Total cash, cash equivalents and restricted cash
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Statistical Measurement
Statistical Measurement [Domain]
Common stock exercise price per share
Class of Warrant or Right, Exercise Price of Warrants or Rights
Warrant exercise price
Total current assets
Assets, Current
Stock based compensation expense
Share-Based Payment Arrangement, Expense
share based compensation expense
Document Period End Date
Document Period End Date
Title of Individual
Title and Position [Axis]
Fair Value Hierarchy and NAV [Domain]
Exercisable at the end of the period (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Lease effective date
Lease effective date.
Vacation pay
Accrued Vacation, Current
Deferred offering costs [Policy Text Block]
Deferred offering costs.
Deferred Offering Costs
Statement of Financial Position [Abstract]
Restricted Stock Units
Restricted Stock Units (RSUs) [Member]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Antidilutive Security, Excluded EPS Calculation [Table]
Vesting [Axis]
Reconciliation of the Condensed Consolidated Statements of Cash Flows to the Condensed Consolidated Balance Sheets
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]
Class of Stock [Axis]
Staff Related Expenses [Member]
Staff related expenses.
Staff Related Expenses
Convertible conversion price
Preferred Stock, Convertible, Conversion Price, Increase
Cash, cash equivalents, restricted cash and marketable securities
Cash Cash Equivalents Restricted Cash And Marketable Securities
Cash, cash equivalents, restricted cash and marketable securities.
Total liabilities
Liabilities
Financial Instruments [Domain]
Notice Period
Notice period.
Notice period
Aggregate Cash Exercise Price Of Warrants Or Rights
Aggregate cash exercise price of warrants or rights.
Aggregate cash exercise price of warrants or rights
Weighted average shares of common stock outstanding - diluted
Weighted Average Number of Shares Outstanding, Diluted
Weighted average shares outstanding, diluted
Weighted average shares of common stock outstanding - diluted
Entity File Number
Securities Act File Number
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Cover [Abstract]
Cover [Abstract]
Measurement Input Type [Axis]
BP Reservoir
BP Reservoir [Member]
BP Reservoir.
Investments [Domain]
Seltorexant
Seltorexant [Member]
Seltorexant.
Scenario [Domain]
U.S. Treasury Securities
US Treasury Securities [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
Shares authorized for issuance
Number of Operating Segments
Number of operating segments
Sale of Stock [Domain]
External Cost [Member]
External Cost.
External Costs
General and Administrative Expense, Total
General and administrative
General and Administrative Expense
General and administrative expenses
Adjustments to additional paid in capital costs earnings related to stock and warrants issuance.
Adjustments To Additional Paid In Capital Costs Earnings Related To Stock And Warrants Issuance
Costs related to issuance of common stock and warrants
Preferred Stock, Convertible, Conversion Price
Conversion price
Temporary Equity, Liquidation Preference
Liquidation preference
Maximum Potential Proceeds From Exercise Of Warrants
Maximum potential proceeds from exercise of warrants.
Potential proceeds from excersie of warrants
Subsequent Event [Table]
Recent Accounting Pronouncements
New Accounting Pronouncements, Policy [Policy Text Block]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Vesting period
Nature Of Operations And Liquidity Disclosure [Abstract]
Nature Of Operations And Liquidity Disclosure Abstract
Maximum percentage of stock beneficial ownership limitation
Maximum Percentage of Stock Beneficial Ownership Limitation
Maximum percentage of stock beneficial ownership limitation.
Common stock, shares outstanding
Balance (in shares)
Balance (in shares)
Common Stock, Shares, Outstanding
Document Transition Report
Document Transition Report
Total expenses
Operating Expenses
Employees and Non-Employees Stock Option
Employees And Non Employees Stock Option [Member]
Employees and non-employees stock option.
Class of Warrant or Right Exercisable Shares
Class of warrant or right exercisable shares.
Warrants exercisable shares
Scenario 2: Milestone Not Achieved
Scenario 2 Milestone Not Achieved [Member]
Scenario 2 milestone not achieved.
Research and Development Expense, Total
Research and development
Research and Development Expense
Research and development expenses
Fair Value
Debt Securities, Held-to-Maturity, Fair Value
Debt Securities, Held-to-Maturity, Fair Value, Total
Non-cash interest expense associated with the sale of future royalties
Non Cash Interest Expense For Sale Of Future Royalties
Amount of non-cash interest expense associated with the sale of future royalties.
Statement of Cash Flows [Abstract]
Deferred offering costs included in accounts payable or in accrued expenses and other current liabilities
Deferred offering costs included in accounts payable or in accrued expenses and other current liabilities.
Deferred offering costs included in accounts payable or in accrued expenses and other current liabilities
Stock Issued During Period, Value, New Issues
Issuance of common stock and warrants pursuant to a private placement
Preferred stock
Schedule of Stock Option Activity for Employees and Non-Employees
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Assets:
Assets, Fair Value Disclosure [Abstract]
Liquidation preference
Preferred Stock, Liquidation Preference, Value
Equity [Text Block]
Redeemable Preferred Stock and Stockholders' Deficit
Earnings Per Share [Text Block]
Net Loss Per Share of Common Stock
Stock Compensation Expenses Non Cash [Member]
Stock compensation expenses non cash.
Stock Compensation Expenses (Non-cash)
Dividend Yield
Measurement Input, Expected Dividend Rate [Member]
Net loss
Net loss
Total Intrinsic Value Outstanding at the begining of period
Total Intrinsic Value Outstanding at the end of period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Total Intrinsic Value Outstanding
Sale of Future Royalties
Sale Of Future Royalties Disclosure [Text Block]
Sale of future royalties.
Operating lease, cost
Operating Lease, Cost
Warrants expiration term
Warrants and Rights Outstanding, Term
Dividend yield
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Class Of Warrant Or Right, Warrants Or Rights Exercisable
Class of warrant or right, warrants or rights exercisable.
Warrants exercisable
Series A Preferred Stock Warrants [Member]
Series A preferred stock warrants.
Series A Preferred Stock Warrants
Assets
Assets [Abstract]
Risk free interest rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Document Fiscal Year Focus
Document Fiscal Year Focus
Additional milestone payments
Potential Milestone Payments
Potential Milestone Payments
Cash flows from investing activities:
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Accounts Payable, Current, Total
Accounts payable
Accounts Payable, Current
Research and Development
Research and Development Expense [Member]
Royalty Pharma
Royalty Pharma [Member]
Royalty Pharma member.
Prepaid expenses and other current assets
Increase Decrease In Prepaid Expense Other Current Assets
Increase decrease in prepaid expense other current assets.
Fair Value Disclosures [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Sale of Stock, Consideration Received on Transaction
Offering price
Aggregate offering price
Share-Based Payment Arrangement [Abstract]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total
Total unrecognized compensation costs
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Assets, Fair Value
Assets, Fair Value Disclosure
Assets, Fair Value Disclosure, Total
Sale of Stock [Axis]
Net cash provided by investing activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Net cash used in investing activities
Private Placement
Private Placement [Member]
Title of 12(b) Security
Title of 12(b) Security
Schedule of Segment Reporting Information, by Segment [Table]
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Cancelled/forfeited (in dollars per share)
Related and Nonrelated Parties [Domain]
Shares issued
Temporary Equity, Shares Issued
Class Of Warrant Or Right [Line Items]
Class of Warrant or Right [Line Items]
Changes in operating assets and liabilities
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Outstanding at the beginning of period (in dollars per share)
Outstanding at the end of the period (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Fair Value, Recurring and Nonrecurring [Table]
Additional Paid-in Capital
Additional Paid-in Capital [Member]
Non-Cash Other Income
Non-cash other income.
Non-cash other income
Warrant, Exercise Price
Per share in exercise price of warrant. Excludes change due to standard antidilution provision.
Warrant exercise price
Income Statement Location
Statement of Income Location, Balance [Axis]
Trading Symbol
Trading Symbol
Related Party Transaction [Table]
October 2025 Private Placement
October Two Thousand Twenty Five Private Placement [Member]
October two thousand twenty five private placement.
Director [Member]
Directors
Subsequent Event Type [Axis]
Cash flows from financing activities:
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Expected term (years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Accrued Expenses and Other Liabilities
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity Components
Equity Components [Axis]
Incremental Non-cash Compensation Cost
Incremental Non-cash Compensation Cost
Incremental non-cash compensation cost
Debt Securities, Held-to-Maturity [Table Text Block]
Summary of Investments in Held-to-Maturity Securities
Equity Component
Equity Component [Domain]
Reconciling items [Abstract]
Reconciling items.
Reconciling items:
Fair value of the warrants
Derivative, Fair Value, Net
Derivative, Fair Value, Net, Total
Volatility
Measurement Input, Option Volatility [Member]
Securities Purchase Agreement [Member]
Securities purchase agreement.
Securities Purchase Agreement
Depreciation and amortization
Depreciation, Depletion and Amortization, Nonproduction
Depreciation, Depletion and Amortization, Nonproduction, Total
PreferredTrancheAWarrants[Member]
Preferred Tranche A Warrants
Tranche A Warrants
Maximum
Maximum [Member]
Maximum [Member]
Liabilities, Fair Value
Liabilities, Fair Value Disclosure
Liabilities, Fair Value Disclosure, Total
Statistical Measurement
Statistical Measurement [Axis]
Exercised (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Prepaid Expense, Current, Total
Prepaid expenses and other current assets
Prepaid Expense, Current
Common Stock, Value, Issued, Ending Balance
Common Stock, Value, Issued, Beginning Balance
Common Stock, Value, Issued, Total
Common Stock, Value, Issued
Common stock; $0.0001 par value; 250,000,000 shares authorized; 43,841,998 shares issued and outstanding as of March 31, 2026 and 43,274,398 shares issued and outstanding as of December 31, 2025
Consolidation
Consolidation, Policy [Policy Text Block]
Warrants and Rights Outstanding
Fair Value of Series A Warrants
Risk-Neutral Probability of Milestone Event achievement [Member]
Risk-neutral probability of Milestone Event achievement, member.
Risk-Neutral Probability of Milestone Event Achievement
Volatility
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Preferred stock, shares authorized
Preferred Stock, Shares Authorized
Description of transaction
Related Party Transaction, Description of Transaction
Document Entity Information [Abstract]
Document Entity Information Abstract
Related Party Transaction [Line Items]
Entity Registrant Name
Entity Registrant Name
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Warrant Liability
Warrant Liability [Policy Text Block]
Warrant liability.
Subsequent Event [Abstract]
Subsequent Events [Abstract]
Exercise of tranche A warrants
Stock Issued During Period, Value, Exercise of Warrants
Stock issued during period value exercise of warrants.
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Summary of Valuation Inputs
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Terms and manner of settlement
Related Party Transaction, Terms and Manner of Settlement
Consolidation Items [Axis]
Total assets
Assets
Weighted-Average Remaining Contractual Term Exercisable (Years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Exercisable period
Income Statement [Abstract]
Previous Lease
Previous Lease [Member]
Previous lease.
Fair Value of Financial Instruments
Fair Value of Financial Instruments, Policy [Policy Text Block]
Warrant Liability [Text Block]
Warrant Liability.
Warrant Liability
Significant accounting policies.
Significant Accounting Policies [Table]
Significant Accounting Policies [Table]
Common stock issued and sold
Stock Issued During Period, Shares, New Issues
Issuance of common stock
Temporary Equity, Shares Authorized
Shares authorized
Earnings Per Share, Diluted, Total
Earnings Per Share, Diluted
Net loss per share of common stock - diluted
Net loss per share, diluted
Summarizes of Reportable Segment's Financial Information
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Operating Segments [Member]
Operating Segments
Title and Position [Domain]
City Area Code
City Area Code
Counterparty Name
Counterparty Name [Domain]
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]
Segment Reporting Information [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross
Vesting of performance-based restricted stock units (in shares)
Investor
Investor [Member]
Lease expire date
Lease Expiration Date
Cash and Cash Equivalents
Cash and Cash Equivalents, Policy [Policy Text Block]
Pre-funded warrants issuable nominal consideration per share.
Pre-Funded Warrants Issuable Nominal Consideration Per Share
Pre-funded warrants issuable nominal consideration per share
Equipment, net
Property, Plant and Equipment, Net
Property, Plant and Equipment, Net, Total
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total
Beginning of period
End of period
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Loss from operations
Operating Income (Loss)
Accumulated Deficit
Retained Earnings [Member]
Share-based Payment Arrangement, Noncash Expense, Total
Stock-based compensation expense
Share-Based Payment Arrangement, Noncash Expense
Costs paid in connection with private placements
Payments of Stock Issuance Costs
Payment of deferred offering costs
Offering costs
Reverse Stock Split
Reverse Stock Split [Policy Text Block]
Reverse Stock Split [Policy Text Block]
Related party consulting fees
Related Party Consulting Fees
Related party consulting fees.
Scenario 1 Milestone Successfully Achieved [Member]
Scenario 1 milestone successfully achieved.
Scenario 1: Milestone Successfully Achieved
Fair Value, Inputs, Level 1 [Member]
Level 1
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Net cash provided by (used in) financing activities
Net cash provided by financing activities
Per hour service rate
Per Hour Service Rate
Per hour service rate.
Securities Excluded from Calculation of Weighted Average Shares Outstanding as their Effect is Antidilutive
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Corporate Debt Securities [Member]
Corporate Debt Securities
Entity Interactive Data Current
Entity Interactive Data Current
Income Statement Location
Statement of Income Location, Balance [Domain]
Cash flows from operating activities:
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Accretion of marketable securities
Accretion (Amortization) of Discounts and Premiums, Investments
Accretion of marketable securities
Warrants Cash Exercise Price
Warrants cash exercise price.
Aggregate cash exercise price
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
Gain or loss related to changes in fair value of the warrant liability
Changes in fair value of the warrant liability
Maximum Beneficial Ownership Limitation
Maximum beneficial ownership limitation.
Maximum beneficial ownership limitation
Entity Tax Identification Number
Entity Tax Identification Number
Initial Upfront Payment Amortized Interest Expense Potential Milestone Payments Received
Initial upfront payment amortized interest expense potential milestone payments received
Initial upfront payment amortized interest expense potential milestone payments received
Common stock exchanged for PRSUs
Common Stock Exchanged For P R S U S
Common Stock Exchanged For P R S U S
Local Phone Number
Local Phone Number
Related Party Transaction [Domain]
Potential Future Milestone Payment Received
Potential future milestone payment received.
Potential future milestone payments received
Liability related to the sale of future royalties
Liability Related To The Sale Of Future Royalties
Liability related to the sale of future royalties.
Probability Weighted Present Value of the Series a Preferred Warrants [Member]
Probability-weighted present value of the Series A Preferred Warrants.
Probability-Weighted Present Value of the Series A Preferred Warrants
Accounting Policies [Abstract]
Valuation Technique, Binomial Pricing Model [Member]
Binomial Model
Cash and Cash Equivalents
Cash and Cash Equivalents [Member]
Class of Stock [Domain]
Option exchange program.
Option Exchange Program [Member]
Option Exchange Program [Member]
Commercial Paper [Member]
Commercial Paper
Sale of stock issue date
Sale of Stock, Transaction Date
Available for future grant (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Weighted-average period over which unrecognized compensation costs is expected to be recognized
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Professional fees
Accrued Professional Fees, Current
Entity Emerging Growth Company
Entity Emerging Growth Company